Important: Trading Action Alert on this Phase 3 Rocket
This is a Trading Action Alert. A Trading Action Alert requires that you take immediate action on the stock that we are writing to you about. One of your Phase 3 Rockets has announced that its Phase 3 trial for prostate cancer did not meet the required endpoint. This is bad news because the trial is not a success.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.